ICIS Open Science SM Card-ver2

Eye Health Initiative

Eye health is a vital component of overall well-being, as vision plays a central role in daily functioning, independence, and quality of life.

Phase I
Systems Architecture
Systems Architecture
Status: Completed
The Systems Architecture of Eye health is published as a web based tool open to public.
Phase II
Publications
Publications
Status: In Progress
A peer-reviewed paper from the Eye Health Initiative will be published. This phase is in progress.
Phase III
In Silico Modeling
In Silico Modeling
Status: Open
In this phase will develop mathematical models of Eye disease. This phase is yet to begin.
Phase IV
Combination Screening
Combination Screening
Status: Open
This phase will identify target compounds in Eye diseases pathogenesis.
Phase V
Patents
Patents
Status: Open
In this phase, a US patent will be filed for the newly discovered combination(s).
Phase VI
Licensing and Manufacturing
Licensing and Manufacturing
Status: Open
The Eye health Initiative will license and manufacture nutraceuticals to support treatment of Eye diseases.

The Open Science Institute’s Eye Health Initiative has now progressed to the First phase — Systems Architecture. We need your support to move forward. Our goal is to raise $150,000 to research and reveal to the scientific community, highlighting the powerful potential of eye health. Please support this initiative.

Background on Eye Infections

Eye health is a vital component of overall well-being, as vision plays a central role in daily functioning, independence, and quality of life. The eye is a highly specialized organ, susceptible to damage from internal and external factors that can lead to conditions such as age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, and cataracts. Four primary contributors to declining eye health include oxidative stress, retinal degeneration, inflammation, and vascular dysfunction.Oxidative stress results from an imbalance between free radicals and antioxidants in the eye, which can damage the retina and lens proteins, contributing to diseases like AMD and cataracts. Retinal degeneration involves the deterioration of photoreceptor cells, often associated with aging or genetic disorders, leading to vision loss. Inflammation plays a dual role—while it is part of the body’s immune response, chronic ocular inflammation can damage retinal tissues and accelerate disease progression. Vascular dysfunction, particularly affecting the delicate capillaries of the retina, is a key factor in diabetic retinopathy and other ischemic eye diseases. Maintaining eye health requires a multifaceted approach, including a nutrient-rich diet (high in lutein, zeaxanthin, vitamin A, C, E, and omega-3 fatty acids), regular eye exams, blood sugar control for diabetics, protection from UV radiation, and avoiding smoking. Advances in systems biology and in silico modeling offer promising avenues for identifying molecular targets and developing personalized therapies to prevent or reverse ocular diseases. As life expectancy increases, proactive management of eye health becomes essential to preserving vision and enhancing quality of life.

Systems Architecture

The Systems Architecture of Eye Health is published as a Web-based tool open to public.

Publication

A peer-reviewed publication resulting from the work of Eye health Initiative will be published journal. This phase is in progress

In Silico Modeling

In this phase, in silico modeling will be performed to develop mathematical models representing the biological process involved in Eye disease pathogenesis. This phase is yet to begin.

Combination Screening

In this phase, combination screening will be performed to identify potential ingredient/compounds that target the biological process implicated in Eye Infections pathogenesis. This phase is yet to begin.

Patents

In this phase, a US patent will be filed for the combination(s) discovered in the Combination Screening phase. This phase is yet to begin.

Licensing and Manufacturing

The Eye Health Initiative plans to discover, develop, license and manufacture proprietary nutraceuticals to support treatment of Eye Health Support our mission to bring this innovation to those who need it most. Please support this phase by donating to the Eye Health Initiative

Health-product-label-09-10-2025